
About Proteon Therapeutics
Proteon Therapeutics is a publicly listed company based in Waltham (United States) founded in 2001. Developer of cell therapies and investigational drug formulations for cancer and rare diseases. Proteon Therapeutics has raised $126.54 million across 6 funding rounds from investors including Bessemer Venture Partners, RA Capital and Perceptive Advisors. The company has 17 employees. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.
Company details
Founded in 2001 and based in Waltham, United States, Proteon Therapeutics operates in the biotechnology sector. Cell therapies for non-muscle invasive bladder cancer and lymphatic malformations are developed, alongside investigational phospholipid substrate replacement therapies for patients requiring parenteral support. Novel approaches are applied by combining modern scientific advancements with established mechanisms to advance treatment options for cancer and rare diseases.
- Headquarters Waltham, United States
- Employees 17
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website proteontherapeutics.com
- Social LinkedIn X
- Total Equity Funding$126.54M (USD)
in 6 rounds
- Latest Funding Round$22M (USD), Post-IPO
Aug 2017
- InvestorsBessemer Venture Partners
& 13 more
- Employee Count17
Funding Insights of Proteon Therapeutics
Proteon Therapeutics has successfully raised a total of $126.54M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $22 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $126.54M
- Total Rounds 6
- Last Round Post-IPO β $22M
- First Round $12M
(Sep 2007)
- Investors Count 14
All 6 funding rounds of Proteon Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | $22M | Post-IPO | β | β | |
| May 2014 | $45M | Series D | β | Abingworth | |
| Feb 2014 | $4.34M | Series B | β | β | β |
| Aug 2011 | $15.2M | Series B | β | β | β |
| May 2009 | $50M | Series B | β | β | |
| Sep 2007 | $12M | Series A | β | β |
14 investors in total: 14 institutional.
Investors in Proteon Therapeutics
Proteon Therapeutics has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Bessemer Venture Partners, RA Capital and Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Early stage venture capital firm investing in US | 1973 | abingworth.com | London, United Kingdom | |
Early-stage life sciences and tech focused VC firm funding companies in the US | intersouth.com | Durham, United States | ||
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
US life sciences companies are invested in by Skyline Ventures. | skylineventures.com | Palo Alto, United States | ||
Capital is invested in life science innovations for healthcare transformation. | tvm-capital.com | Munich, Germany | ||
VC firm investing in the US | prismventure.com | Westwood, United States | ||
| dpbioventures.com | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | bvp.com | Redwood City, United States | |
Delivers investment management services with a focus on portfolio construction and risk assessment. | 2016 | fairmountfunds.com | Philadelphia, United States |
Investor details for Proteon Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Proteon Therapeutics
34 people are tracked at Proteon Therapeutics (17 in leadership, 9 in board & advisors, 8 in team); the tracked headcount is 17.
| Name | Role | Group |
|---|---|---|
Melissa Patterson | Director - Clinical Finance & Contracting | Leadership |
Karen Lee Errigo, PHR | Associate Director Human Resources | Leadership |
Brian Desch | Director Clinical Operations | Leadership |
Hannah F. | VP, Controller | Leadership |
Patrick Fabbio | Chief Financial Officer | Leadership |
Jennifer Steinle | Executive Assistant to Chief Executive Officer | Leadership |
Jesse Shefferman | Co-Founder, Director & CEO | Leadership |
Jacqueline Zummo | Co-Founder, SVP & Chief Scientific Operations Officer | Leadership |
Maurizio M. | Senior Director, Lead Principal Scientist | Leadership |
Lisa Schlesinger | VP New Product Development And Market Access | Leadership |
Sam Greene, CPA | Associate Director, Assistant Controller | Leadership |
Andrea DiFiglia | Associate Director, Clinical Sciences | Leadership |
McKenna Metcalf | Director Clinical Operations | Leadership |
Eppie Brown | Vice President, Clinical Operations | Leadership |
Bill Conkling | Chief Commercial Officer (cco) | Leadership |
Leo Viana Nicacio | Chief Medical Officer | Leadership |
Khushboo Belani | Senior Director, Clinical Sciences And Regulatory Affairs | Leadership |
Richard Levy | Director | Board & advisors |
Michael Solomon | Director | Board & advisors |
Barry Flannelly | Director | Board & advisors |
14 more people are available in the full profile.
Complete people profiles for Proteon Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Proteon Therapeutics
4 dated milestones of Proteon Therapeutics across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Proteon Therapeutics is founded.
- Funding First funding round of $12.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $22.0M.
Web traffic of Proteon Therapeutics
Websites that share an audience with Proteon Therapeutics (proteontherapeutics.com).
Websites whose visitors overlap most with Proteon Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| momentapharma.com | 100% | #11,284,544 | View details | ||
| proteonsoftware.com | 84% | View details |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Proteon Therapeutics (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Proteon Therapeutics
Proteon Therapeutics was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Proteon Therapeutics is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Proteon Therapeutics is a funded company, having raised a total of $126.54M across 6 funding rounds to date. The company's 1st funding round was a Series A of $12M, raised on Sep 2007.
Proteon Therapeutics has 17 employees.
Founded in 2001 and based in Waltham, United States, Proteon Therapeutics operates in the biotechnology sector. Cell therapies for non-muscle invasive bladder cancer and lymphatic malformations are developed, alongside investigational phospholipid substrate replacement therapies for patients requiring parenteral support. Novel approaches are applied by combining modern scientific advancements with established mechanisms to advance treatment options for cancer and rare diseases.
Proteon Therapeutics has 14 investors. Key investors include Bessemer Venture Partners, RA Capital, Perceptive Advisors, Abingworth, and Deerfield.